Home/Filings/4/0001104659-22-072059
4//SEC Filing

Drutz David 4

Accession 0001104659-22-072059

CIK 0001326190other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 9:27 PM ET

Size

5.6 KB

Accession

0001104659-22-072059

Insider Transaction Report

Form 4
Period: 2022-06-15
Drutz David
Director
Transactions
  • Purchase

    Common Stock, par value $0.0001

    2022-06-15$8.00/sh+1,000$8,00020,012 total
Holdings
  • Common Stock, par value $0.0001

    (indirect: See Footnote)
    333
Footnotes (1)
  • [F1]Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1
  • filerCIK 0001428764

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 9:27 PM ET
Size
5.6 KB